company score funding investors employees industries biz model city contact
ViaNautis

Drug delivery platform.

42
$24M · Series A 4BIO Capital, UCB Ventures, Business Growth Fund 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@vianautis.com
Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

37
$56M · Series B Balderton Capital, Atomico, Amadeus Capital 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Harness Therapeutics

Physiological upregulation therapy to treat neurodegenerative diseases.

37
$5M · Seed SV Health Investors 11 to 50 Health Tech, Biotech Cambridge, UK •••••••••••@harnesstx.com
Zetta Genomics

Genomic data analysis platform.

37
$2M · Seed We Venture Capital, Nina Capital, LinkedIn 11 to 50 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@zettagenomics.com
Sano Genetics

AI platform to advance precision medicine clinical trials.

37
$11M · Series A Seedcamp, Plural, Episode 1 11 to 50 Health Tech, Biotech B2B, SaaS Cambridge, UK •••••••••••@sanogenetics.com
Microbiotica

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

37
$66M Seventure Partners, Cambridge Innovation Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@microbiotica.com
Nuclera

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

31
$42M · Series B Future Planet Capital, Amadeus Capital, Verve Ventures 11 to 50 Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@nuclera.com
bit.bio

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

31
$41M · Series A Metaplanet Holdings, BlueYard Capital 101 to 250 Health Tech, Biotech, Deep Tech, Business Intelligence B2B Cambridge, UK •••••••••••@bit.bio
Mogrify

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

31
$10M · Series A Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors 101 to 250 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@mogrify.co.uk
Mosaic Therapeutics

Anti-cancer drug developer.

31
$28M · Series A Syncona Partners LLP, Cambridge Innovation Capital 101 to 250 Biotech Cambridge, UK •••••••••••@mosaic-tx.com
evonetix

DNA synthesis technology researcher.

31
$24M · Series B Foresite Capital 11 to 50 Biotech Cambridge, UK •••••••••••@evonetix.com
Broken String Biosciences

Genomics company building safer cell and gene therapies.

31
$15M · Series A Tencent, Illumina Ventures 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@brokenstringbio.com
Eagle Genomics

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

26
$3M · Seed ETF Partners, Granpool Innovative Investments 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@eaglegenomics.com
Mestag Therapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

26
$11M · Seed GV, Forbion Capital Partners 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@mestagtx.com
Epitopea

Epitopea is a transatlantic cancer immunotherapeutics company.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

26
$6M · Series A Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments 51 to 100 Health Tech, Biotech Cambridge, UK •••••••••••@missiontherapeutics.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
PetMedix

PetMedix is a pet therapeutics startup.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
Axol Bioscience

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
Qkine

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

26
$5M · Series B Parkwalk Advisors, Downing Ventures 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@qkine.com
HexagonFab

HexagonFab is the biological sensor for rapid and cost-effective detection of biological substances.

21
$2M · Seed Parkwalk Advisors 1 to 10 Hardware, Biotech, Manufacturing, Business Intelligence B2B Cambridge, UK •••••••••••@hexagonfab.com
Semarion

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

21
$2M · Seed Parkwalk Advisors, Martlet Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@semarion.com
Xampla

Plant-based biodegradable material producer.

21
$2M · Seed Amadeus Capital, Horizons Ventures, Parkwalk Advisors 1 to 10 Biotech B2B Cambridge, UK •••••••••••@xampla.com
Transine Therapeutics

Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

17
$12M · Seed 11 to 50 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@transinetx.com
Charco Neurotech

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

17
$692k · Pre Seed Amadeus Capital, Parkwalk Advisors 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@charconeurotech.com
CardiaTec Biosciences

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

17
$1M · Pre Seed LinkedIn 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@cardiatec.ai
Biofidelity HIRING

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

17
$940k · Seed Octopus Ventures, Longwall Venture, BlueYard Capital 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@biofidelity.com
Upfront Diagnostics

Clinical stage studies to discover biomarkers to improve medical diagnosis.

17
$2M · Seed 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@upfrontdiagnostics.com
NRG Therapeutics

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

17
$18M 1 to 10 Health Tech, Biotech, Pharma B2B Cambridge, UK •••••••••••@nrgtherapeutics.com
Psyomics

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

17
$1M Parkwalk Advisors, Martlet Capital 11 to 50 Health Tech, Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@psyomics.com
Better Origin

The food chain is broken. Our technology fixes it.

17
$791k · Pre Seed Balderton Capital, Fly Ventures 11 to 50 Agritech, Foodtech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@betterorigin.co.uk
PharmEnable

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

14
$2M · Seed 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@pharmenable.com
Monocl

Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.

14
$3M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@monocl.com
Congenica

Congenica is a biotechnology company that provides a diagnostic decision support platform.

12
N/A QVentures, Cambridge Innovation Capital, Parkwalk Advisors 11 to 50 Health Tech, Biotech, Genetics B2B Cambridge, UK •••••••••••@congenica.com
Legacy

Legacy is a digital fertility clinic for men, founded at Harvard & backed by Y Combinator, FirstMark Capital, Bain Capital and celebrities.

7
N/A 101 to 250 Health Tech, Biotech, Proptech & Real Estate, Femtech, Mobile, Energy & Nuclear, Genetics, Business Intelligence, Fertility B2B, SaaS Cambridge, UK •••••••••••@givelegacy.com
CellCentric

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

7
N/A 1 to 10 Biotech, Deep Tech Cambridge, UK •••••••••••@cellcentric.com
Base4

A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.

4
N/A 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@base4.co.uk
Entomics

Entomics is a biotechnology platform that transforms food waste into sustainable, renewable resources with the use of insects.

4
N/A 1 to 10 Biotech, Energy & Nuclear Cambridge, UK •••••••••••@entomics.com
DIOSynVax

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

4
N/A 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@diosvax.com
BIOS

A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.

4
N/A 11 to 50 Biotech, Data and Analytics Cambridge, UK •••••••••••@bios.health
Abcam

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.

4
N/A 1001 to 5000 Biotech, Deep Tech Cambridge, UK •••••••••••@abcam.com